European Medicines Agency plans public access to information on side effects

The European Medicines Agency, on 8 July 2011, published its plans for granting public access to the information held in its databases of the potential side effects of human and veterinary medicines.

The two policies published on 8 July explain the Agency's plans to release information held in its EudraVigilance and EudraVigilance Veterinary databases. These are the central repositories for reports of suspected adverse reactions related to medicines authorised in the European Economic Area and medicines being studied in clinical trials.